Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
APG1244
i
Other names:
APG1244, APG1252 prodrug, BM-1244, APG-1252-M1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Twitter
Trials
Company:
Ascentage Pharma
Drug class:
Bcl2 inhibitor, Bcl-xL inhibitor
Related drugs:
‹
venetoclax (383)
paclitaxel (163)
albumin-bound paclitaxel (57)
ABT 263 (16)
APG-2575 (7)
APG-1252 (6)
micellar paclitaxel (3)
BGB-11417 (1)
paclitaxel oral (1)
oral paclitaxel/encequidar (1)
AT 101 (1)
S55746 (1)
A-1331852 (5)
venetoclax (383)
paclitaxel (163)
albumin-bound paclitaxel (57)
ABT 263 (16)
APG-2575 (7)
APG-1252 (6)
micellar paclitaxel (3)
BGB-11417 (1)
paclitaxel oral (1)
oral paclitaxel/encequidar (1)
AT 101 (1)
S55746 (1)
A-1331852 (5)
›
Associations
(2)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
MCL1 overexpression
Colorectal Cancer
MCL1 overexpression
Colorectal Cancer
APG1244 + MCL1 inhibitor
Sensitive: D – Preclinical
APG1244 + MCL1 inhibitor
Sensitive
:
D
APG1244 + MCL1 inhibitor
Sensitive: D – Preclinical
APG1244 + MCL1 inhibitor
Sensitive
:
D
MCL1 overexpression
Colorectal Cancer
MCL1 overexpression
Colorectal Cancer
APG1244
Resistant: D – Preclinical
APG1244
Resistant
:
D
APG1244
Resistant: D – Preclinical
APG1244
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login